Seres Health fetches $48 mln
Seres Health has raised $48 million in Series C funding. The investors in this round were not named; however, the firm was seeded by Flagship Ventures. Based in Cambridge, Mass., Seres Health is a biotherapeutic company focused on developing drugs that target the human microbiome.
2 December 2014•2 mins read
